A Study of N-Acetylcysteine (N-AC)in People Receiving CAR T-cell Therapy for Lymphoma
Status:
Not yet recruiting
Trial end date:
2023-10-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety of N-AC when given in combination with
Yescarta to people with lymphoma. This study will test different doses of N-AC to find the
highest dose that causes few or mild side effects in participants.